Antheia is a science and technology company developing next generation plant-inspired medicines. The company applies synthetic biology, genomics, bioinformatics, enzyme engineering, and fermentation to produce plant-based active pharmaceutical ingredients (APIs) in more controlled and economical ways using brewer’s yeast, their production organism of choice. They also develop advanced analytics and modeling tools to optimize, streamline, and systematize their discovery and design processes, using in-house data sets and a data-driven approach.
Antheia strives to accelerate the discovery of new medicines and create more equitable channels of distribution, disrupting the traditional agricultural-based supply chain.